Skip to main content
Clinical Trials/ACTRN12609000937213
ACTRN12609000937213
Completed
N/A

A randomised controlled trial of a family-centred tobacco control program about environmental tobacco smoke (ETS) to reduce respiratory illness in Indigenous infants.

Menzies School of Health Research0 sites420 target enrollmentNovember 2, 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Menzies School of Health Research
Enrollment
420
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 2, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Infants will be eligible for inclusion if: 1\. They are aged between 0\-5 weeks. We will review our recruitment rate four months after the trial has commenced. If we find that we are not meeting our enrolment targets, we will consider extending our recruitment to include infants aged 5\-10 weeks. This will allow us to approach mothers and their infants at 6\-8 weeks when they present at community health clinics for their first immunizations. 2\. Their mother/caregiver is Indigenous (defined by maternal self\-identification). 3\. Their mother/caregiver is aged 16 years or over. 4\. Their mother/caregiver currently smokes or if the infant lives in a household where there is at least one other person who smokes (defined as smoking at least weekly). 5\. Their mother/caregiver plans to reside permanently with the infant in Darwin or Greater Darwin areas of Australia or within the Counties Manukau District Health Board region, Manukau, NZ. 6\. Their mother/caregiver has given signed written consent to participate in this research study. 7\. Their mother/caregiver has given signed written consent for study staff to access the infant’s health records. 8\. They are a singleton or the first born in a multiple pregnancy delivery. 9\. Their mother/caregiver speaks English and/or Maori.

Exclusion Criteria

  • Infants will be excluded from the trial if:
  • 1\. They have serious neonatal respiratory complications (i.e. they require oxygen for \>24 hours during their postnatal hospital stay).
  • 2\. They have other serious neonatal complications (e.g. seizures, significant sepsis).
  • 3\. They have major organ abnormalities (i.e. cardiac disease, congenital lung/diaphragm abnormalities, chromosomal abnormality or syndrome e.g. Down’s syndrome).
  • 4\. Their mother/caregiver has previously been recruited in this research study.
  • 5\. They live in the same household as a mother/caregiver who has previously been recruited in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials